1. National Research Council. Commission on Life Sciences Board on Environmental Studies and Toxicology. Committee on Biological Markers, Subcommittee on Biologic Markers in Urinary Toxicology. In: Biologic Markers in Urinary Toxicology. National Academy Press, Washington DC 1995; p. 16–21.
2. Bennett WM, Elzinga LW, Porter GA. Tubulointerstitial disease and toxic nephropathy. In: The Kidney. Brenner BM, Rector FC, Jr, (editors). WB Saunders, Philadelphia. London. Toronto, Montreal, Sydney, Tokyo 1991; p. 1430–1496.
3. Deistan HP. Renovascular hypertension and azotemia. N Engl J Med 1984; 311: 1114–1116.
4. Goering PL, Fowler BA. Regulation of lead inhibition of delta aminolevulinic acid dehydratase by high affinity lead-binding protein. J Pharmacol Exp Ther 1984; 231: 66–71.
5. Morgensen CE. Urinary albumin excretion in early and long term juvenile diabetes. Scand J Clin Lab Invest 1971: 281: 101–109.